Therapeutic Oligonucleotides

61Citations
Citations of this article
227Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A brief historical introduction describes early attempts to silence specific genes using the antisense oligonucleotides that flourished in the 1980s. Early aspirations for therapeutic applications were almost extinguished by the unexpected complexity of oligonucleotide pharmacology. Once the biochemistry and molecular biology behind some of the pharmacology was worked out, new approaches became apparent for using oligonucleotides to treat disease. The biochemistry of small nucleic acids is outlined in Section 2. Various approaches employing oligonucleotides to control cellular functions are reviewed in Section 3. These include antisense oligonucleotides and siRNA that bind to RNA, antigene oligonucleotides that bind to DNA, and aptamers, decoys, and CpG oligonucleotides that bind to proteins.

Cite

CITATION STYLE

APA

Goodchild, J. (2011). Therapeutic Oligonucleotides. In Methods in Molecular Biology (Vol. 764, pp. 1–15). Humana Press Inc. https://doi.org/10.1007/978-1-61779-188-8_1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free